Transcription-Coupled & Replication-Associated Excision Repair
转录偶联
基本信息
- 批准号:7924234
- 负责人:
- 金额:$ 35.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:ATP HydrolysisATP phosphohydrolaseAffectAntineoplastic AgentsApoptosisAtomic Force MicroscopyBase Excision RepairsBindingCancer EtiologyCatalytic DomainCellsCellular biologyCockayne SyndromeCollaborationsComplexComprehensive Cancer CenterCoupledCouplingCrystallographyDNADNA DamageDNA RepairDNA StructureDefectDevelopmentDiseaseElectron MicroscopyExcision RepairFigs - dietaryGenetic TranscriptionGenomeHealthHumanImageryLeadLesionLigaseLinkMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingModificationMolecularMolecular TargetMutagenesisMutationN-terminalNucleotide Excision RepairNucleotidesOutcomePainPathway interactionsPatientsPhosphorylationPost-Translational Protein ProcessingPredispositionProcessProteinsRNA Polymerase IIRecombinantsRoentgen RaysRoleRotationSWI2/SNF2Signal TransductionSlideStructureTestingTranscription ElongationTranscription-Coupled RepairUV sensitive syndromeXPGC proteinXRCC1 genebasedeprivationdevelopmental diseasedrug discoveryflexibilityiliummutY adenine glycosylasemutantoxidative DNA damageoxidative damageprotein complexprotein protein interactionrepair enzymerepairedresponsestoichiometrytranscription factor TFIIHultraviolet damage
项目摘要
The Project (Transcription-Coupled and Replication-Associated Excision Repair) focuses on mechanisms coupling DNA excision repair machinery with transcription and replication. Both
Nucleotide Excision Repair (NER) and Base Excision Repair (BER) are highly coordinated by interactions
between proteins in the pathway. Moreover, they are preferentially targeted by specialized transcriptioncoupled
repair (TCR) machinery to lesions that affect transcription elongation or by replication-associated
repair (RAR) to lesions near the replication fork or in recently replicated DNA. We hypothesize that these
interactions and their effects on function are regulated through unstructured flexible regions that undergo
disorder-to-order transformations upon complex formation and/or post-translational modifications. We will
test this overall hypothesis and specific hypotheses in five Aims by collaborative studies to characterize,
validate, and map interactions, identify damage-induced modifications, observe effects of complexes on DNA
structure by scanning force microscopy (SFM), and visualize subunits and complexes by electron
microscopy (EM), small angle X-ray scattering (SAXS), and protein crystallography (PX). Aim 1 will
structurally characterize early steps of TCR: recognition by XPG and CSB of RNA Polymerase II (RNAPII)
stalled at a lesion, and remodeling of RNAPII by TFIIH to allow access to the lesion. SFM and EM studies
will test the hypothesis that these occur by ordered conformational changes. Aim 2 will structurally
characterize CSB and reinvestigate its causal role in CS by determining whether mutant CSB interferes with
responses to oxidative DNA damage through non-productive interactions with other proteins in the pathway.
Aim 3 will investigate the identified interactions that couple BER and NER to transcription through (a) SAXS
and PX studies of XPG protein and its domains and complexes, (b) analysis of interactions of NEIL2 with
RNAPII, XPG and CSB, and (c) characterization of the effect of post-translational modifications on XPG and
NEIL2 interactions. Aim 4 will characterize the structural basis for BER pathway coordination by interactions
of NEIL1 and NEIL2 glycosylases with downstream BER proteins and test the hypothesis that BER pathway
progression results in progressive DNA bending. Aim 5 will investigate molecular mechanisms of RAR by
determining the structure of the checkpoint sliding clamp -- the 9-1-1 complex - and by characterizing
interactions of the MYH and NEIL1 glycosylases with PCNA and 9-1-1. The anticipated outcome is a
molecular understanding of cancer predispositions and developmental disorders that arise from defects in
the coordination of excision repair with transcription and replication. Collaborations of Project 2 within SBDR
and with the UCSF Comprehensive Cancer Center will relate results of these studies to genome integrity and
cancer etiology as well as to development of promising molecular targets for cancer drug discovery.
该项目(转录偶联和复制相关切除修复)重点研究 DNA 切除修复机制与转录和复制的耦合机制。两个都
核苷酸切除修复(NER)和碱基切除修复(BER)通过相互作用高度协调
途径中的蛋白质之间。此外,它们优先被专门的转录偶联靶向
修复(TCR)机制对影响转录延伸或复制相关损伤的损伤
对复制叉附近或最近复制的 DNA 中的损伤进行修复 (RAR)。我们假设这些
相互作用及其对功能的影响是通过非结构化的灵活区域来调节的,这些区域经历
复杂形成和/或翻译后修饰时的无序到有序转化。我们将
通过合作研究来检验这一总体假设和五个目标中的具体假设,以表征,
验证和绘制相互作用图谱,识别损伤引起的修饰,观察复合物对 DNA 的影响
通过扫描力显微镜 (SFM) 观察结构,并通过电子可视化亚基和复合物
显微镜 (EM)、小角 X 射线散射 (SAXS) 和蛋白质晶体学 (PX)。目标1将
结构表征 TCR 的早期步骤:XPG 和 CSB 对 RNA 聚合酶 II (RNAPII) 的识别
停滞在病变处,并通过 TFIIH 重塑 RNAPII 以允许到达病变处。 SFM 和 EM 研究
将检验这些是通过有序构象变化发生的假设。目标 2 将在结构上
通过确定突变 CSB 是否干扰来表征 CSB 并重新研究其在 CS 中的因果作用
通过与途径中其他蛋白质的非生产性相互作用来应对氧化 DNA 损伤。
目标 3 将研究已确定的通过 (a) SAXS 将 BER 和 NER 与转录耦合的相互作用
XPG 蛋白及其结构域和复合物的 PX 研究,(b) NEIL2 与
RNAPII、XPG 和 CSB,以及 (c) 翻译后修饰对 XPG 和 CSB 影响的表征
NEIL2 相互作用。目标 4 将通过相互作用来表征 BER 通路协调的结构基础
NEIL1 和 NEIL2 糖基化酶与下游 BER 蛋白的结合,并测试 BER 通路的假设
进展导致DNA逐渐弯曲。目标 5 将通过以下方式研究 RAR 的分子机制:
确定检查点滑动夹具的结构——9-1-1复合体——并通过表征
MYH 和 NEIL1 糖基化酶与 PCNA 和 9-1-1 的相互作用。预期结果是
对癌症易感性和由缺陷引起的发育障碍的分子理解
切除修复与转录和复制的协调。 SBDR 内项目 2 的合作
并与加州大学旧金山分校综合癌症中心合作,将这些研究结果与基因组完整性和
癌症病因学以及开发用于癌症药物发现的有前景的分子靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Priscilla K. Cooper其他文献
Priscilla K. Cooper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Priscilla K. Cooper', 18)}}的其他基金
Genomic Instability from Loss of XPG, a BRCA1/2 Partner: Role in Ovarian Cancer?
XPG(BRCA1/2 伙伴)缺失导致基因组不稳定:在卵巢癌中的作用?
- 批准号:
8885778 - 财政年份:2014
- 资助金额:
$ 35.54万 - 项目类别:
Novel Interactions of DNA Repair Processes in Replication Fork Maintenance
复制叉维护中 DNA 修复过程的新相互作用
- 批准号:
8404020 - 财政年份:2012
- 资助金额:
$ 35.54万 - 项目类别:
Novel Interactions of DNA Repair Processes in Replication Fork Maintenance
复制叉维护中 DNA 修复过程的新相互作用
- 批准号:
8246242 - 财政年份:2012
- 资助金额:
$ 35.54万 - 项目类别:
Novel Interactions of DNA Repair Processes in Replication Fork Maintenance
复制叉维护中 DNA 修复过程的新相互作用
- 批准号:
8758773 - 财政年份:2012
- 资助金额:
$ 35.54万 - 项目类别:
Novel Interactions of DNA Repair Processes in Replication Fork Maintenance
复制叉维护中 DNA 修复过程的新相互作用
- 批准号:
8572128 - 财政年份:2012
- 资助金额:
$ 35.54万 - 项目类别:
Environmental Mutagen Society 48th Annual Meeting
环境诱变剂学会第48届年会
- 批准号:
7614132 - 财政年份:2008
- 资助金额:
$ 35.54万 - 项目类别:
Transcription-Coupled & Replication-Associated Excision Repair
转录偶联
- 批准号:
7152382 - 财政年份:2006
- 资助金额:
$ 35.54万 - 项目类别:
Gordon Research Conference on Mammalian DNA Repair
戈登哺乳动物 DNA 修复研究会议
- 批准号:
7018524 - 财政年份:2003
- 资助金额:
$ 35.54万 - 项目类别:
EMB-ML Expression, Molecular Biology and MacroLab Core
EMB-ML 表达、分子生物学和 MacroLab 核心
- 批准号:
8555260 - 财政年份:2001
- 资助金额:
$ 35.54万 - 项目类别:
相似海外基金
Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
- 批准号:
10568723 - 财政年份:2023
- 资助金额:
$ 35.54万 - 项目类别:
Mechanism of Substrate Unfolding by the AAA+ ATPase p97 and Binding Partners
AAA ATPase p97 和结合伙伴的底物解折叠机制
- 批准号:
10678124 - 财政年份:2023
- 资助金额:
$ 35.54万 - 项目类别:
Mechanistic Investigation of Proteostasis at the Outer Mitochondrial Membrane
线粒体外膜蛋白质稳态的机制研究
- 批准号:
10684120 - 财政年份:2023
- 资助金额:
$ 35.54万 - 项目类别:
Loss of VCP Function in Frontotemporal Lobar Degeneration
额颞叶变性导致 VCP 功能丧失
- 批准号:
10440933 - 财政年份:2022
- 资助金额:
$ 35.54万 - 项目类别:
How SSB Regulates YoaA-chi's Function in DNA Damage Repair
SSB 如何调节 YoaA-chi 的 DNA 损伤修复功能
- 批准号:
10684693 - 财政年份:2022
- 资助金额:
$ 35.54万 - 项目类别: